Neuroscientist: “You Could Create a False Reality With Brain Chips”

The conversation opens with a discussion of Neuralink, with the neuroscientist drawing a parallel to existing deep brain stimulation (DBS) technology already used in neurosurgery. She explains that DBS involves dropping electrodes into the brain, similar to a pacemaker, and has proven effective in treating Parkinson's disease tremors. While she acknowledges Neuralink's potential to help with disease states, she expresses uncertainty about Elon Musk's broader intentions.

When asked whether brain chips could project a false reality into someone's mind, the neuroscientist confirms this is probable and frames it as genuinely frightening. She supports this claim by drawing a parallel to drug-induced psychosis, describing a personal account of watching someone close to her develop induced psychosis and schizophrenia over seven years through escalating drug use from cocaine and ecstasy to methamphetamine. Her argument is that if drugs can create a false reality, a chip likely could too.

The discussion then shifts to marijuana, which the neuroscientist characterizes as harmful. She argues that despite its popular use as a sleep aid, marijuana does not produce genuine sleep — it merely sedates users, preventing the deep and REM sleep stages the brain requires. She also warns of its potential to cause psychosis and hallucinations with heavy long-term use and describes it as highly addictive. She does, however, distinguish CBD oil as a non-psychoactive component of the cannabis plant with legitimate medical applications, particularly for epilepsy patients.

In the final segment, the neuroscientist pivots to brain health recommendations. She emphasizes omega-3 fatty acids, explaining that 70% of the brain is composed of fat and water, largely DHA, which is one of the three molecules in omega-3s alongside EPA and ALA. She notes that omega-3s literally feed the brain with what it is made of, cite research linking them to Alzheimer's disease treatment, and mentions the MFS2DA transporter that shuttles DHA into the brain and becomes dysfunctional in Alzheimer's patients. She recommends 2g each of DHA and EPA daily. She closes with broader lifestyle advice including resistance training, aerobic exercise, and crucially, getting at least 7.5 hours of sleep per night, citing a PNAS study showing that just one night of sleep deprivation (six hours or less) increases amyloid beta — a hallmark of Alzheimer's — by 5%.